BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31444550)

  • 1. Therapeutic outcome and prognostic factors in sinonasal rhabdomyosarcoma: a single-institution case series.
    Li W; Lu H; Wang D
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2793-2802. PubMed ID: 31444550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Population-Based Analysis of Survival for Sinonasal Rhabdomyosarcoma.
    Unsal AA; Chung SY; Unsal AB; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):142-149. PubMed ID: 28397540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy analysis of adult sinonasal rhabdomyosarcoma].
    Bai Y; Chen X; Yan Y; Zhang S; Zhou W; Fang J; Huang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(9):804-10. PubMed ID: 26281056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes.
    Thompson CF; Kim BJ; Lai C; Grogan T; Elashoff D; St John MA; Wang MB
    Int Forum Allergy Rhinol; 2013 Aug; 3(8):678-83. PubMed ID: 23424037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in Adult Sinonasal Rhabdomyosarcoma.
    Stepan K; Konuthula N; Khan M; Parasher A; Del Signore A; Govindaraj S; Genden E; Iloreta A
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):135-141. PubMed ID: 28669309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.
    Ding J; Wang C; Xiang J; Shen C; Hu C; Xu T; Lu X
    Med Sci Monit; 2018 Sep; 24():6113-6118. PubMed ID: 30173244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic traits and prognostic factors associated with pediatric sinonasal rhabdomyosarcoma.
    Siddiqui SH; Siddiqui E; Bavier RD; Patel NM; KiliƧ S; Baredes S; Hsueh WD; Eloy JA
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):363-369. PubMed ID: 30629809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of paediatric sinonasal rhabdomyosarcoma.
    Fyrmpas G; Wurm J; Athanassiadou F; Papageorgiou T; Beck JD; Iro H; Constantinidis J
    J Laryngol Otol; 2009 Sep; 123(9):990-6. PubMed ID: 19393123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyosarcomas of the nose and paranasal sinuses: treatment results in 15 cases.
    Wurm J; Constantinidis J; Grabenbauer GG; Iro H
    Otolaryngol Head Neck Surg; 2005 Jul; 133(1):42-50. PubMed ID: 16025051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients.
    Guntinas-Lichius O; Kreppel MP; Stuetzer H; Semrau R; Eckel HE; Mueller RP
    Eur J Surg Oncol; 2007 Mar; 33(2):222-8. PubMed ID: 17127030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic surgery for primary sinonasal malignancies: Treatment outcomes and prognostic factors.
    Huang Y; Qiu QH; Zhang SX
    Ear Nose Throat J; 2018 Jun; 97(6):E24-E30. PubMed ID: 30036420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
    J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended orbital exenteration for sinonasal malignancy with orbital apex extension: surgical technique and clinical analysis.
    Sugawara T; Aoyagi M; Ogishima T; Kawano Y; Tamaki M; Yano T; Tsunoda A; Ohno K; Maehara T; Kishimoto S
    J Neurosurg; 2015 Jul; 123(1):52-8. PubMed ID: 25816080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD; Fleming JC; Haik BG; Wilson MW
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children.
    Callender TA; Weber RS; Janjan N; Benjamin R; Zaher M; Wolf P; el-Naggar A
    Otolaryngol Head Neck Surg; 1995 Feb; 112(2):252-7. PubMed ID: 7838548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyosarcoma of nose and paranasal sinuses--a therapeutic challenge.
    Sinha R; Bandyopadhyay SN; Pathak K; Hati G
    J Indian Med Assoc; 2006 Sep; 104(9):519-21. PubMed ID: 17388011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical study.
    Fuchs J; Dantonello TM; Blumenstock G; Kosztyla D; Klingebiel T; Leuschner I; Schuck A; Niggli FK; Koscielniak E; Seitz G
    Ann Surg; 2014 Jun; 259(6):1166-72. PubMed ID: 24045440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.